<DOC>
	<DOCNO>NCT00834938</DOCNO>
	<brief_summary>Bariatric surgery lead improvement even resolution type 2 diabetes 80 % patient submit Roux-en-Y gastric bypass ( RYGP ) . Otherwise , many patient experienced resolution diabetes despite massive surgical-induced weight loss . There appear variable response surgery depend surgical patient factor . To explore potential factor affect diabetes outcomes RYGP , study propose make description effect surgical procedure incretin , insulin production sensitivity comparison patient without remission Type 2 Diabetes .</brief_summary>
	<brief_title>Comparison Between Patients With Without Diabetes Recovery After Bariatric Surgery</brief_title>
	<detailed_description>Diabetes reversion observe bariatric surgery even significant weight loss could explain , mainly predominantly malabsorptive procedure ( 98,9 % biliopancreatic diversion duodenal switch ) , follow combine malabsorption gastric restriction ( 83,7 % Roux-en-Y gastric bypass ) . Changes hormonal communication digestive system pancreas would explain antidiabetogenic role surgery , effect could obtain nonobese , diabetic individual . To explore potential factor affect diabetes outcomes RYGP , study propose make description effect surgical procedure incretin , insulin production sensitivity comparison patient without remission Type 2 Diabetes .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Gastric Inhibitory Polypeptide</mesh_term>
	<criteria>Capacity understand procedure study . To agree voluntarily participate study , sign informed consent . Weight variance le 5 % last 3 month . Operative group least 2 year followup . History hepatic disease like cirrhosis chronic active hepatitis . Kidney dysfunction ( creatinine &gt; 1,4 mg/dl woman &gt; 1,5 mg/dl men ) . Hepatic dysfunction : ALT and/or AST 3x upper normal limit ) . Recent history neoplasia ( &lt; 5 year ) . Use oral injectable consecutive 14 day last three month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>diabetes mellitus , type 2</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>bariatric surgery</keyword>
	<keyword>Glucagon-Like Peptide 1</keyword>
	<keyword>Gastric Inhibitory Polypeptide</keyword>
	<keyword>insulin</keyword>
	<keyword>glucagon</keyword>
	<keyword>ghrelin</keyword>
	<keyword>adiponectin</keyword>
	<keyword>Cytokines</keyword>
	<keyword>gastric bypass</keyword>
	<keyword>Obesity</keyword>
</DOC>